Machine Learning METiS Announces Pan-RAF Inhibitor License Agreement with Voronoi AIT News Desk Sep 13, 2022 METiS Therapeutics, a Boston-area company integrating drug discovery and delivery with AI and machine learning, announced they have entered a license…
Life Sciences METiS Therapeutics Launches With $86 Million Series A Financing to Transform Drug Discovery and… AIT News Desk Dec 12, 2021 METiS Therapeutics debuts with $86 million Series A financing to harness artificial intelligence (AI) and machine learning to redefine drug discovery…